Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily GW685698X nasal spray in vasomotor/idiopathic rhinitis
2004-004743-22Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate in non-allergic rhinitis (NAR) and Perennial Nonallergic Rhinitis (NAR) (2 arms), sponsored by GSK. Primary endpoint: Mean change from baseline in daily reflective total symptom score over the entire treatment period. Started Feb 2005; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
non-allergic rhinitis (NAR)Perennial Nonallergic Rhinitis (NAR)
Beyond the preview
Go deeper on 2004-004743-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004743-22.